Cabozantinib (XL184)
Cabozantinib (XL184) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM in cell-free assays, respectively. Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway.
Supplier | Selleck Chemicals |
---|---|
Product # | S1119 |
Sku # | S1119-50mg |
Pricing | 50mg, $470.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2020Quote: ... Cabozantinib (Selleck Chemicals S1119), Sunitinib (Selleck Chemicals S7781 ...